A detailed history of Federated Hermes, Inc. transactions in Myriad Genetics Inc stock. As of the latest transaction made, Federated Hermes, Inc. holds 56,599 shares of MYGN stock, worth $777,670. This represents 0.0% of its overall portfolio holdings.

Number of Shares
56,599
Previous 56,807 0.37%
Holding current value
$777,670
Previous $1.39 Million 11.52%
% of portfolio
0.0%
Previous 0.0%

Shares

27 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 13, 2024

SELL
$23.97 - $28.6 $4,985 - $5,948
-208 Reduced 0.37%
56,599 $1.55 Million
Q2 2024

Aug 08, 2024

BUY
$17.98 - $25.47 $15,211 - $21,547
846 Added 1.51%
56,807 $1.39 Million
Q1 2024

May 14, 2024

BUY
$17.59 - $23.59 $16,745 - $22,457
952 Added 1.73%
55,961 $1.19 Million
Q4 2023

Jan 31, 2024

SELL
$13.91 - $21.32 $21,324 - $32,683
-1,533 Reduced 2.71%
55,009 $1.05 Million
Q3 2023

Nov 13, 2023

SELL
$15.99 - $23.22 $15 - $23
-1 Reduced -0.0%
56,542 $906,000
Q2 2023

Aug 14, 2023

SELL
$17.56 - $23.76 $30,519 - $41,294
-1,738 Reduced 2.98%
56,543 $1.31 Million
Q1 2023

May 08, 2023

BUY
$15.26 - $23.75 $27,178 - $42,298
1,781 Added 3.15%
58,281 $1.35 Million
Q4 2022

Feb 13, 2023

BUY
$14.51 - $20.99 $15,191 - $21,976
1,047 Added 1.89%
56,500 $819,000
Q3 2022

Nov 14, 2022

SELL
$18.21 - $27.88 $396,286 - $606,724
-21,762 Reduced 28.18%
55,453 $1.06 Million
Q2 2022

Aug 15, 2022

SELL
$16.45 - $25.88 $568,627 - $894,593
-34,567 Reduced 30.92%
77,215 $1.4 Million
Q1 2022

May 13, 2022

SELL
$22.67 - $28.01 $239,100 - $295,421
-10,547 Reduced 8.62%
111,782 $2.82 Million
Q4 2021

Feb 14, 2022

BUY
$24.13 - $32.63 $712,655 - $963,694
29,534 Added 31.83%
122,329 $3.38 Million
Q3 2021

Nov 15, 2021

BUY
$29.97 - $36.66 $827,981 - $1.01 Million
27,627 Added 42.39%
92,795 $3 Million
Q2 2021

Aug 16, 2021

SELL
$25.39 - $32.61 $6,576 - $8,445
-259 Reduced 0.4%
65,168 $1.99 Million
Q1 2021

May 13, 2021

SELL
$19.92 - $31.6 $135,615 - $215,132
-6,808 Reduced 9.42%
65,427 $1.99 Million
Q4 2020

Feb 12, 2021

SELL
$12.16 - $19.77 $8.27 Million - $13.4 Million
-679,748 Reduced 90.39%
72,235 $1.43 Million
Q3 2020

Nov 12, 2020

SELL
$11.25 - $14.75 $6.86 Million - $8.99 Million
-609,441 Reduced 44.76%
751,983 $9.81 Million
Q2 2020

Aug 13, 2020

BUY
$10.69 - $16.49 $6.25 Million - $9.63 Million
584,219 Added 75.17%
1,361,424 $15.4 Million
Q1 2020

May 13, 2020

BUY
$9.78 - $29.53 $7.6 Million - $23 Million
777,205 New
777,205 $11.1 Million
Q3 2019

Nov 14, 2019

SELL
$22.08 - $47.08 $2.7 Million - $5.75 Million
-122,085 Closed
0 $0
Q2 2019

Aug 14, 2019

BUY
$22.67 - $35.0 $874,381 - $1.35 Million
38,570 Added 46.18%
122,085 $3.39 Million
Q1 2019

May 10, 2019

SELL
$26.93 - $34.7 $1.06 Million - $1.36 Million
-39,212 Reduced 31.95%
83,515 $2.77 Million
Q4 2018

Feb 13, 2019

SELL
$27.23 - $45.56 $2.86 Million - $4.79 Million
-105,192 Reduced 46.15%
122,727 $3.57 Million
Q3 2018

Nov 13, 2018

BUY
$37.57 - $50.34 $600,857 - $805,087
15,993 Added 7.55%
227,919 $10.5 Million
Q2 2018

Aug 10, 2018

BUY
$27.75 - $40.17 $3.21 Million - $4.65 Million
115,784 Added 120.43%
211,926 $7.92 Million
Q1 2018

May 09, 2018

BUY
$28.83 - $41.01 $2.67 Million - $3.79 Million
92,478 Added 2523.96%
96,142 $2.84 Million
Q3 2017

Nov 13, 2017

BUY
$24.01 - $36.2 $87,972 - $132,636
3,664
3,664 $133,000

Others Institutions Holding MYGN

About MYRIAD GENETICS INC


  • Ticker MYGN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Diagnostics & Research
  • Shares Outstandng 80,634,800
  • Market Cap $1.11B
  • Description
  • Myriad Genetics, Inc., a genetic testing and precision medicine company, develops and commercializes genetic tests in the United States and internationally. The company offers molecular diagnostic tests for use in oncology, and women's and mental health applications. It provides MyRisk Hereditary Cancer Test, a DNA sequencing test for assessing ...
More about MYGN
Track This Portfolio

Track Federated Hermes, Inc. Portfolio

Follow Federated Hermes, Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Federated Hermes, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Federated Hermes, Inc. with notifications on news.